These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26093813)

  • 21. Negative predictors of treatment success in outpatient therapy of arterial hypertension in Poland. Results of the CONTROL NT observational registry.
    Filipiak KJ; Tomaniak M; Płatek AE; Szymański FM; Tykarski A
    Kardiol Pol; 2018; 76(2):353-361. PubMed ID: 29131289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
    Chobanian AV; Bakris GL; Black HR; Cushman WC; Green LA; Izzo JL; Jones DW; Materson BJ; Oparil S; Wright JT; Roccella EJ; ;
    JAMA; 2003 May; 289(19):2560-72. PubMed ID: 12748199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hypertension in patients with CKD: differences between primary and tertiary care settings.
    Minutolo R; De Nicola L; Zamboli P; Chiodini P; Signoriello G; Toderico C; Arfè G; Boschi G; Brancati C; Iaccarino P; Conte G
    Am J Kidney Dis; 2005 Jul; 46(1):18-25. PubMed ID: 15983953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
    Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
    J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.
    Karpov YA; Gorbunov VM; Deev AD
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):417-25. PubMed ID: 26351011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood Pressure Target Achievement Under Monotheraphy: A Real-Life Appraisal.
    Tocci G; Presta V; Citoni B; Figliuzzi I; Bianchi F; Ferrucci A; Volpe M
    High Blood Press Cardiovasc Prev; 2020 Dec; 27(6):587-596. PubMed ID: 33165768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial treatment of hypertension and adherence to therapy in general practice in Italy.
    Poluzzi E; Strahinja P; Vargiu A; Chiabrando G; Silvani MC; Motola D; Sangiorgi Cellini G; Vaccheri A; De Ponti F; Montanaro N
    Eur J Clin Pharmacol; 2005 Sep; 61(8):603-9. PubMed ID: 16082539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Strategies for improving blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. 2012 Position paper of the Italian Society of Hypertension].
    Volpe M; Ambrosioni E; Borghi C; Cottone S; Cuspidi C; De Luca N; Fallo F; Ferri C; Morganti A; Muiesan ML; Sarzani R; Sechi L; Virdis A; Tocci G; Agabiti-Rosei E; Trimarco B; Filippi A; Mancia G;
    G Ital Cardiol (Rome); 2012 Dec; 13(12):853-60. PubMed ID: 23196689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex differences in antihypertensive drug use and blood pressure control.
    Wang J; Jiang W; Sharma M; Wu Y; Li J; You N; Ding Z; Zhao X; Chen H; Tang H; Zhou X; Li X
    Postgrad Med J; 2019 Jun; 95(1124):295-299. PubMed ID: 31171709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescribing pattern of antihypertensive drugs by family physicians and general practitioners in the primary care setting in Bahrain.
    Sequeira RP; Jassim KA; Damanhori AH; Mathur VS
    J Eval Clin Pract; 2002 Nov; 8(4):407-14. PubMed ID: 12421390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of selective imidazoline receptor agonists in modern hypertension management: an international real-world survey (STRAIGHT).
    Schlaich MP; Almahmeed W; Arnaout S; Prabhakaran D; Zhernakova J; Zvartau N; Schutte AE
    Curr Med Res Opin; 2020 Dec; 36(12):1939-1945. PubMed ID: 33047993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficulties in reaching therapeutic goals for hypertension and dysplipidaemia in patients with type 2 diabetes in general practice.
    Knudsen ST; Mosbech TH; Hansen B; Kønig E; Johnsen PC; Kamper AL
    Dan Med J; 2013 Dec; 60(12):A4740. PubMed ID: 24355449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General practitioners' approach to hypertension in urban Pakistan: disturbing trends in practice.
    Jafar TH; Jessani S; Jafary FH; Ishaq M; Orakzai R; Orakzai S; Levey AS; Chaturvedi N
    Circulation; 2005 Mar; 111(10):1278-83. PubMed ID: 15769769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA; Hemmelgarn B; Herman RJ; Rabkin SW; McAlister FA; Bell CM; Touyz RM; Padwal R; Leiter LA; Mahon JL; Hill MD; Larochelle P; Feldman RD; Schiffrin EL; Campbell NR; Arnold MO; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Ogilvie RI; Hamet P; Fodor G; Carruthers G; Burns KD; Ruzicka M; dechamplain J; Pylypchuk G; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Vallée M; Howlett J; Katzmarzyk P; Tobe S; Lewanczuk RZ;
    Can J Cardiol; 2008 Jun; 24(6):465-75. PubMed ID: 18548143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-line treatment of essential hypertension: A real-world analysis across four antihypertensive treatment classes.
    Stapff M; Hilderbrand S
    J Clin Hypertens (Greenwich); 2019 May; 21(5):627-634. PubMed ID: 30980608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Khan NA; Hemmelgarn B; Padwal R; Larochelle P; Mahon JL; Lewanczuk RZ; McAlister FA; Rabkin SW; Hill MD; Feldman RD; Schiffrin EL; Campbell NR; Logan AG; Arnold M; Moe G; Campbell TS; Milot A; Stone JA; Jones C; Leiter LA; Ogilvie RI; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Burns KD; Ruzicka M; deChamplain J; Pylypchuk G; Gledhill N; Petrella R; Boulanger JM; Trudeau L; Hegele RA; Woo V; McFarlane P; Touyz RM; Tobe SW;
    Can J Cardiol; 2007 May; 23(7):539-50. PubMed ID: 17534460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.